Abstract: An object of the present invention is to find a novel pharmaceutical that has an excellent tryptophanase inhibitory effect, and suppresses worsening of renal function to preserve the kidney by reducing production of indoxyl sulfate in the blood. Provided is a pharmaceutical composition containing, as an active ingredient, a compound represented by formula (I) or a pharmacologically acceptable salt thereof. In the formula (I), R1 and R2 are the same or different, and represent a C1-C6 alkyl group, a halogeno C1-C6 alkyl group or a C3-C6 cycloalkyl group; n represents 0, 1 or 2; each X represents a C1-C6 alkyl group, a C3-C6 cycloalkyl group, a halogen atom or the like; and Y represents a hydrogen atom, a C1-C6 alkoxy group, a C3-C6 cycloalkoxy group or a halogeno C1-C6 alkoxy group.

Abstract: Provided is a control rod motion monitoring method and a control rod motion monitoring system, in which a control rod insertion in an entire core is monitored at all time during operation of a reactor and, when an abnormality occurs, a signal is issued to a countermeasure device that automatically starts operation and an alarm is issued to prompt operation of an operator. An LPRM detector in an LPRM assembly of the entire core is divided into four channels for each height; indicated values are averaged at all time; the average indicated value is compared with a set point; and a signal is issued to a countermeasure device when an abnormality occurs.

Abstract: An external device is configured to be detachably attached to a measuring instrument via a connector. The external device includes a connector part, an external device body part and a movable connection part. The connector part has a connection terminal. The external device body part has a display part on a side surface of the external device body part. The movable connection part is configured to connect the connector part with the external device body part. The movable connection part is a biaxial rotation hinge having two pivot axes which are in a twisted position relationship with respect to each other.

Abstract: A control rod operation generates a rod insertion block signal during operation of a reactor. Four neutron detector assemblies including a plurality of LPRMs arranged in an axial direction of a core are arranged adjacent to a plurality of insertion selection control rods, respectively, which are simultaneously inserted into the core. Neutron flux ratio calculation units are arranged in each of the neutron detector assemblies, and ratios (neutron flux ratios BA/AA, CA/AA, and DA/AA) of an average LPRM signal of the respective LPRMs at positions B, C, and D to an average LPRM signal of the respective LPRMs at a position A which is closest to the control rod insertion end of the core are calculated. When the largest neutron flux ratio out of the neutron flux ratios exceeds a set neutron flux ratio, a rod insertion block signal which is generated by a local range rod insertion monitor is output.

Abstract: Provided is a hydrogen concentration measuring device capable of measuring with high accuracy a hydrogen concentration over an extensive range by a simple configuration. The device includes: a sensor chip which detects the electric resistance of a sensing film; an optical measurement unit which detects the transmitted light intensity of the film; and a controller. The controller performs measurement processing such that a hydrogen concentration in the gas atmosphere is measured based on the detected electric resistance in a first measurement range and based on the detected transmitted light intensity in a second measurement range and is determined so as to reduce a difference between the hydrogen concentration based on the detected electric resistance and the hydrogen concentration based on the detected transmitted light intensity in the overlap of the first measurement range and the second measurement range.

Abstract: A measuring instrument includes a measuring unit, an electric component unit and a pin jack. The electric component unit includes a signal processing part. The signal processing part is configured to calculate a measurement data based on a detection signal obtained by the measuring unit. The pin jack is provided in the electric component unit.

Abstract: A solid-state light source lighting device includes an adjuster configured to adjust an output current to be output through an output port, and a first switch to be electrically connected in parallel with a second LED of a plurality of solid-state light sources, and a controller configured to turn on and off the first switch. The controller is configured to keep the first switch off while the DC voltage (input voltage) received through the input port is higher than a threshold voltage, and keep the first switch on while the input voltage is lower than or equal to the threshold voltage. The threshold voltage is higher than or equal to a voltage necessary to turn on the plurality of solid-state light sources while the first switch is off.

Abstract: It is intended to provide a novel bisphosphonic acid compound or a salt thereof which shows a remarkable inhibitory effect on ectopic calcification, and a pharmaceutical composition comprising the same. The present invention provides a bisphosphonic acid compound represented by the following formula (1) or a pharmaceutically acceptable salt thereof: wherein represents a single bond or a double bond; A represents a saturated cyclic hydrocarbon or a saturated heterocyclic ring comprising a sulfur atom or an oxygen atom; and R1 and R2 each independently represent an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an aryloxy group, a haloalkoxy group, a haloalkyl group, a halogen atom or a hydrogen atom.

Abstract: A measurement probe is configured to be detachably connected to a biological optical measurement apparatus that performs an optical measurement on body tissue. The measurement probe includes an illumination fiber configured to irradiate the body tissue with illumination light, and a plurality of detection fibers configured to detect return light of at least one of the illumination light reflected from the body tissue and the illumination light scattered from the body tissue. On a plane which is away from distal ends of the illumination fiber and the plurality of detection fibers and through which the illumination light and the return light can pass, a detection area of the return light in each of the plurality of detection fibers is included in all of an illumination area of the illumination fiber or inside of the illumination area.

Abstract: A manufacturing method for a group III nitride semiconductor substrate is provided with a first step of forming a second group III nitride semiconductor layer on a substrate; a second step of forming a protective layer on the second group III nitride semiconductor layer; a third step of selectively forming pits on dislocation portions of the second group III nitride semiconductor layer by gas-phase etching applied to the protective layer and the second group III nitride semiconductor layer; and a fourth step of forming a third group III nitride semiconductor layer on the second group III nitride semiconductor layer and/or the remaining protective layer so as to allow the pits to remain.

Abstract: It is an object to provide a removal function of removing impurities from exhaust gas including rare gas (for example, argon, xenon, krypton and the like) that is used in an excimer laser oscillation device, in a system of the excimer laser oscillation device. The excimer laser oscillation device including a gas recycle function includes an oscillation chamber in which laser gas having halogen gas, rare gas and buffer gas is filled inside, a first impurity removing device that removes impurities in exhaust gas that is discharged from the oscillation chamber, inside the system of the excimer laser oscillation device.

Abstract: The problem with which the present invention is concerned is providing a novel pharmaceutical preparation, the restrictions on the administration of which to a patient are more relaxed than those of a conventional spherical carbon adsorbent, which can be simultaneously taken with other drugs and, moreover, which is reduced in dosage. The problem can be solved by a pharmaceutical preparation for oral administration comprising a porous material, wherein a means for exposing a surface of the porous material for the first time in the large intestine or a lower part of the small intestine is provided on the porous material.

Abstract: A solid-state light source lighting device includes an adjuster configured to adjust an output current to be output through an output port, and a first switch to be electrically connected in parallel with a second LED of a plurality of solid-state light sources, and a controller configured to turn on and off the first switch. The controller is configured to keep the first switch off while the DC voltage (input voltage) received through the input port is higher than a threshold voltage, and keep the first switch on while the input voltage is lower than or equal to the threshold voltage. The threshold voltage is higher than or equal to a voltage necessary to turn on the plurality of solid-state light sources while the first switch is off.

Abstract: An external device is configured to be detachably attached to a measuring instrument via a connector. The external device includes a connector part, an external device body part and a movable connection part. The connector part has a connection terminal. The external device body part has a display part on a side surface of the external device body part. The movable connection part is configured to connect the connector part with the external device body part. The movable connection part is a biaxial rotation hinge having two pivot axes which are in a twisted position relationship with respect to each other.

Abstract: An interference fringe generating optical system generates an interference fringe, and a magnifying optical system magnifies the interference fringe and projects the interference fringe on an object surface. The magnifying optical system includes an incident-side lens group on the side where a light beam forming the interference fringe is incident and an exit-side lens group on the side where the light beam is emitted and the interference fringe is projected towards the object surface. The expression f1/f2>3 holds, where f1 is the focal length of the incident-side lens group, and f2 is the focal length of the exit-side lens group. The incident-side and exit-side lens groups each have a positive refractive power. The expression xd/(f1+f2)<2 is satisfied, where xd is the distance from the exit-side principal point of the incident-side lens group to the incident-side principal point of the exit-side lens group.

Abstract: Provided is a display device that can be readily reduced in size and thickness, and is capable of reducing luminance unevenness within an image. The display device includes: a projection optical system that projects image light at infinity; and a first propagation optical system, a second propagation optical system, and a third propagation optical system, which sequentially enlarge, in one direction, the image light projected from the projection optical system, in which the image light output from the third propagation optical system allows an image to be observed.

Abstract: A measuring instrument includes a measuring unit, an electric component unit and a pin jack. The electric component unit includes a signal processing part. The signal processing part is configured to calculate a measurement data based on a detection signal obtained by the measuring unit. The pin jack is provided in the electric component unit.

Abstract: A shock absorber according to one embodiment includes a damper case provided to hold an outer tube and an inner tube such that an upper end of the outer tube is positioned closer to a side on which a piston rod is disposed than an upper end of the inner tube. The damper case includes a damper housing portion that houses a damper unit, a compression-side communication path through which an inner side of the inner tube and the damper housing portion communicate with each other, an extension-side communication path through which an annular passage and the damper housing portion communicate with each other, and a passage opening which is formed on the opposite side to the piston rod of the outer tube. The extension-side communication path and the annular passage communicate with each other through the passage opening.

Abstract: A measurement probe is configured to be detachably connected to a bio-optical measurement apparatus and includes: an illuminating fiber configured to irradiate body tissues with illumination light; light receiving fibers configured to receive return light of the illumination light reflected and/or scattered from the body tissues; an optical element configured to transmit the illumination light and the return light and to keep distances between the body tissues and distal ends of the illuminating fiber and the light receiving fibers, constant; and a contact detecting fiber configured to receive the return light to detect contact between a distal end face of the optical element and the body tissues, and detect the return light at a detection region on the distal end face through which the illumination light and the return light pass. The detection region is located outside an illumination region of the illuminating fiber.

Abstract: Compounds are provided having an excellent hypoglycemic effect and ? cell- or pancreas-protecting effects, or pharmaceutically acceptable salts thereof, and a pharmaceutical composition having an excellent therapeutic effect and/or prophylactic effect on type 1 diabetes, type 2 diabetes, and the like, which cause hyperglycemia due to abnormal glucose metabolism. A compound represented by general formula (I), or a pharmaceutically acceptable salt thereof, is disclosed.